Randomized Double Blind Parallel Groups Sequential, Placebo Controlled, Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome (RLS)
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2018
At a glance
- Drugs BP 14979 (Primary)
- Indications Restless legs syndrome
- Focus Proof of concept; Therapeutic Use
- Sponsors Bioprojet
- 07 Feb 2018 Status changed from not yet recruiting to recruiting.
- 17 Jan 2018 Planned initiation date changed from 1 Jan 2018 to 31 Jan 2018.
- 20 Nov 2017 New trial record